Literature DB >> 19950023

Graves' orbitopathy: current imaging procedures.

Eberhard Kirsch1, Beat Hammer, Georg von Arx.   

Abstract

In patients with Graves' orbitopathy (GO), magnetic resonance imaging (MRI) is a valuable tool to distinguish the acute inflammatory active disease from fibrotic, inactive end stage disease in demonstrating interstitial oedema within the extraocular muscles on coronal TIRM-sequences. MRI is the modality of choice to identify active inflammatory changes and to assess any immunomodulatory treatment response. MRI is always required in doubtful cases, as e.g., asymmetrical orbital involvement, to exclude any other orbital pathology and the clinical suspicion of dysthyroid optic nerve compression in Graves' orbitopathy. Computed tomography (CT) provides precise imaging of the osseous periorbital structures, but does not reveal information on the disease activity in most cases. It is therefore the method of choice to plan CT-guided orbital decompression surgery in the inactive phase of GO.

Entities:  

Mesh:

Year:  2009        PMID: 19950023     DOI: smw-12741

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  21 in total

1.  [Diagnosis and differential diagnosis of Graves' orbitopathy in MRI].

Authors:  D Daubner; S Spieth; K Engellandt; R von Kummer
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

2.  Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.

Authors:  H C Kim; S W Yoon; H Lew
Journal:  Br J Radiol       Date:  2015-07-07       Impact factor: 3.039

3.  Update on advanced imaging options for thyroid-associated orbitopathy.

Authors:  Michael P Rabinowitz; Jacqueline R Carrasco
Journal:  Saudi J Ophthalmol       Date:  2012-10

4.  CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy.

Authors:  Zhi-Jia Fang; Jenny Y Zhang; Wei-Min He
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

Review 5.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

6.  Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease.

Authors:  R Kilicarslan; A Alkan; M M Ilhan; H Yetis; A Aralasmak; E Tasan
Journal:  Br J Radiol       Date:  2014-12-19       Impact factor: 3.039

7.  Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy.

Authors:  Dong-Dong Xu; Yu Chen; Hai-Yan Xu; Hui Li; Zhu-Hua Zhang; Yu-Hua Liu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

8.  Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.

Authors:  Fabio Tortora; Mariaevelina Prudente; Mario Cirillo; Andrea Elefante; Maria Paola Belfiore; Francesco Romano; Salvatore Cappabianca; Carlo Carella; Sossio Cirillo
Journal:  Neuroradiology       Date:  2014-02-27       Impact factor: 2.804

9.  Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.

Authors:  Fabio Tortora; Mario Cirillo; Marco Ferrara; Maria Paola Belfiore; Carlo Carella; Ferdinando Caranci; Sossio Cirillo
Journal:  Neuroradiol J       Date:  2013-11-07

10.  Bilateral metastatic melanoma to the extraocular-muscles simulating thyroid eye disease.

Authors:  Ana Catarina Almeida; Adrian Fung; Marta Esteves Guedes; João Marques Costa
Journal:  BMJ Case Rep       Date:  2012-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.